These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6369502)

  • 41. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of magnesium on the renin-angiotensin-aldosterone system in human subjects.
    Ichihara A; Suzuki H; Saruta T
    J Lab Clin Med; 1993 Oct; 122(4):432-40. PubMed ID: 8228558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiotensin II type 1 receptor messenger RNA levels in human blood cells of patients with primary and secondary hypertension: reference to renin profile.
    Shibata H; Suzuki H; Murakami M; Sato A; Saruta T
    J Hypertens; 1994 Nov; 12(11):1275-84. PubMed ID: 7868875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hypertensions caused by hypermineralocorticism].
    Fournier A; Lagrue G
    Sem Hop; 1971 Mar; 47(14):872-89. PubMed ID: 4324368
    [No Abstract]   [Full Text] [Related]  

  • 46. [Excess mineralocorticoid syndrome secondary to nasal sprays containing 9 alpha-fluoroprednisolone].
    Foresti V; Parisio E; Ricci G
    Minerva Med; 1987 Sep; 78(17):1305-11. PubMed ID: 2444906
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered secretion of corticosteroids and prolactin in adrenal regeneration hypertensive rats.
    Mimou N; Takeda R
    Endocrinol Jpn; 1992 Apr; 39(2):185-96. PubMed ID: 1396350
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pathogenesis of arterial hypertension with a low renin activity in the blood plasma].
    Shkhvatsabaia IK; Chikhladze NM; Ustinova SE
    Kardiologiia; 1978 Nov; 18(11):5-11. PubMed ID: 364165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Reliability and diagnostic use of the furosemide test in the study of the renin-angiotensin-aldosterone system].
    Cugini P; Scavo D
    Boll Soc Ital Cardiol; 1978; 23(8):1267-83. PubMed ID: 398707
    [No Abstract]   [Full Text] [Related]  

  • 50. Adrenal cancer with hypertension but low plasma renin and aldosterone.
    Cheng WY; Chang TC; Chu TS; Tsai TC; Hsieh HC
    J Formos Med Assoc; 1999 Jan; 98(1):73-5. PubMed ID: 10063279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renin, aldosterone and other mineralocorticoids in hyperkalemic patients with chronic renal failure showing mild azotemia.
    Saruta T; Nagahama S; Eguchi T; Oka M; Kanbegawa A
    Nephron; 1981; 29(3-4):128-32. PubMed ID: 7035983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Do weak mineralocorticoids affect the pathogenesis of hypertension in Cushing's disease?
    Hermus A; Hobma S; Pieters G; Benraad T; Smals A; Kloppenborg P
    J Hypertens Suppl; 1989 Dec; 7(6):S208-9. PubMed ID: 2698926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Interference of canrenoate potassium with plasma renin activity. Note I. Effects of canrenoate potassiumon plasma renin activity in patients with essential hypertension].
    Consolo F; Ferraù O; Pitrone F; Luzza G; Russo A; Virga T
    Boll Soc Ital Biol Sper; 1975 Dec; 51(24):1943-9. PubMed ID: 1231877
    [No Abstract]   [Full Text] [Related]  

  • 54. Knowledge of the hormonal peculiarities of essential arterial hypertension may direct therapy and prevent errors.
    Popovici D; Cristoveanu A; Stefănescu AM; Juvină E
    Endocrinologie; 1980; 18(4):225-34. PubMed ID: 6111115
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mineralocorticoid biosynthesis in patients with hyporeninemic hypoaldosteronism.
    Tuck ML; Mayes DM
    J Clin Endocrinol Metab; 1980 Feb; 50(2):341-7. PubMed ID: 6986396
    [No Abstract]   [Full Text] [Related]  

  • 56. Deviation of plasmatic aldosterone and significance of the stimulating (ACTH-cortrosyn) and inhibitory (propranolol) effects in hypertension and cardiovascular pathology.
    Cristoveanu A; Popovici D; Ciocîrdia C; Tache A; Radian N
    Endocrinologie; 1978; 16(2):129-31. PubMed ID: 209529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pattern of plasma renin activity and aldosterone system in patients with sustained hydronephrosis.
    Ezzat M
    Int Urol Nephrol; 1987; 19(1):55-63. PubMed ID: 3294713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Renin activity and functional status of the adrenal cortex in surgical intervention during ketamine anesthesia].
    Belov VA; Vasil'ev VI; Gerasimov GM; Vishnevskaia IG
    Vestn Khir Im I I Grek; 1979 Feb; 122(2):95-8. PubMed ID: 442425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An approach to mineralocorticoid hormone hypertension.
    Biglieri EG
    Cardiovasc Clin; 1978; 9(1):91-7. PubMed ID: 667888
    [No Abstract]   [Full Text] [Related]  

  • 60. The renin-aldosterone system in secondary hypertension: relationship to blood pressure and plasma electrolytes.
    Chen WY; Hsieh BS; Lien WP; Chen FW; Yen TS
    Taiwan Yi Xue Hui Za Zhi; 1980 Apr; 79(4):398-404. PubMed ID: 6995560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.